Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-091438

Chief Financial Officer sold 7,909 shares at $14.52 ($114,851)

From the SEC's structured data for this filing

Trades in this filing

FRATES JAMES M · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form −7,909 $14.52 $114,851 165,638 D
Open-market sales · 7,909 sh · avg $14.52 · $114,851
Loading xslF345X05/ownership.xml…